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Abstract
Background: Endoscopic vein harvest (EVH) was introduced in 1996 as an alternative to open vein harvest
(OVH) for coronary artery bypass graft (CABG) surgeries utilizing the saphenous vein. EVH has been shown
to decrease post operative pain, wound complications, and length of hospital stay. Although EVH has become
the preferred method of saphenous vein harvest, the effect of EVH on graft patency has not been well studied.
A study published in the New England Journal of Medicine in 2009 concluded that EVH was independently
linked to increased morbidity and decreased graft patency. This surprising conclusion was not endorsed by the
cardiothoracic community. Much debate about the effect of EVH on graft patency has ensued, however,
surgical practice appears to have remained unchanged. The potential harm of EVH must be weighed against its
proven benefits in the light of the large number of patients that undergo EVH annually as the predominant
mode of saphenous vein harvest
Methods: An exhaustive literature search was performed using OVID, Web of knowledge, EBMR, CINAHL,
and clinicaltrials.gov with the following search terms: coronary artery bypass graft, endoscopy, saphenous
vein, graft occlusion, and vascular patency. Three studies were identified; two randomized controlled trials and
one retrospective cohort study. Several trials examining graft patency in comparing EVH to OVH that utilized
clinical outcomes (such as myocardial infarction, revascularization, stroke or death) as surrogate endpoints
were excluded.
Results: Of the three included studies, two studies determined that there was no statistical significance in
occlusion rates when comparing EVH to OVH grafts. One study, referenced above, did determine statistically
significant higher occlusion rates in EVH grafts as compared to OVH grafts.
Conclusion: Further research is needed to adequately explore the relationship between EVH and graft
patency associated morbidity. Such research would need to address many confounding variables while
including a large sample population with angiography patency measurements at predetermined time points.
The limited state of current research has failed to demonstrate statistically significant harm that may otherwise
persuade the Society for Thoracic Surgery to ignore the important proven benefits of EVH over OVH. At this
juncture, EVH remains the predominant method of saphenous vein harvest for patients undergoing CABG
surgery.
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Abstract   
 
Background: Endoscopic vein harvest (EVH) was introduced in 1996 as an alternative to open vein 
harvest (OVH) for coronary artery bypass graft (CABG) surgeries utilizing the saphenous vein. EVH 
has been shown to decrease post operative pain, wound complications, and length of hospital stay. 
Although EVH has become the preferred method of saphenous vein harvest, the effect of EVH on graft 
patency has not been well studied.  A study published in the New England Journal of Medicine in 2009 
concluded that EVH was independently linked to increased morbidity and decreased graft patency.  
This surprising conclusion was not endorsed by the cardiothoracic community. Much debate about the 
effect of EVH on graft patency has ensued, however, surgical practice appears to have remained 
unchanged.  The potential harm of EVH must be weighed against its proven benefits in the light of the 
large number of patients that undergo EVH annually as the predominant mode of saphenous vein 
harvest 
Methods:  An exhaustive literature search was performed using OVID, Web of knowledge, EBMR, 
CINAHL, and clinicaltrials.gov with the following search terms: coronary artery bypass graft, 
endoscopy, saphenous vein, graft occlusion, and vascular patency. Three studies were identified; two 
randomized controlled trials and one retrospective cohort study. Several trials examining graft patency 
in comparing EVH to OVH that utilized clinical outcomes (such as myocardial infarction, 
revascularization, stroke or death) as surrogate endpoints were excluded. 
Results:  Of the three included studies, two studies determined that there was no statistical significance 
in occlusion rates when comparing EVH to OVH grafts. One study, referenced above, did determine 
statistically significant higher occlusion rates in EVH grafts as compared to OVH grafts.  
Conclusion: Further research is needed to adequately explore the relationship between EVH and graft 
patency associated morbidity. Such research would need to address many confounding variables while 
including a large sample population with angiography patency measurements at predetermined time 
points.  The limited state of current research has failed to demonstrate statistically significant harm that 
may otherwise persuade the Society for Thoracic Surgery to ignore the important proven benefits of 
EVH over OVH. At this juncture, EVH remains the predominant method of saphenous vein harvest for 
patients undergoing CABG surgery. 
 
Keywords:  coronary artery bypass graft, endoscopy, saphenous vein, graft occlusion, and vascular 
patency 
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Endoscopic versus Open Saphenous Vein Harvest in Patients Undergoing CABG, 
an Angiographically Measured Graft Patency Comparison 
 
BACKGROUND: 
 A recent article in the New England Journal of Medicine (NEJM) rapidly gained the attention 
of the cardiothoracic community.  Lopes et al1 concluded that endoscopic vein harvest (EVH) of the 
saphenous vein for coronary artery bypass graft (CABG) surgery lead to decreased graft patency and 
increased morbidity when compared to saphenous veins harvested by the conventional open vein 
harvest (OVH) technique.1  This surprising conclusion sparked a lively discussion among the 
cardiothoracic community regarding saphenous vein harvest methods and potential subsequent effects 
on graft patency. Despite the conclusion of Lopes et al1, EVH continues to be the predominant method 
of saphenous vein harvest for CABG surgeries.2  This dichotomy sparked a systematic literature 
review of current evidence.  
 EVH was introduced in 1996, to reduce the morbidity associated with OVH wound 
complications in patients undergoing CABG with utilization of the saphenous vein.3 In addition to 
decreased wound complications, EVH has been shown to decrease length of hospital stay and decrease 
postoperative incisional leg pain.4,5  
 Despite the clearly advantageous patient outcomes associated with EVH, the effect of EVH on 
long-term graft patency is not yet clear. Early studies microscopically evaluated vein samples and 
reported acute endothelial changes in veins harvested with EVH.  These changes were generally 
attributed to the manipulation of the endoscope during EVH.  For that reason, there was concern that 
these acute endothelial changes associated with EVH may poorly effect graft quality and therefore 
graft patency. However, a separate study comparing intraoperative vein specimens harvested by both 
techniques showed similar medial smooth-muscle and endothelial function,6,7suggesting that vein 
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quality at the time of anastomoses may in fact be similar between the two techniques. Therefore, 
harvest method may have less of an acute histological effect on vein quality than was previously 
thought. 
 Although histological examination is useful in assessing vein conduit quality, vein quality is 
only one of many factors that may contribute to long-term graft patency. Other confounding variables 
include patient characteristics, such as age, sex, and gender.  Additional intraoperative factors beyond 
method of vein harvest may also affect graft patency. These may include the administration of heparin 
prior to vein harvest, and harvesting technician experience. Finally, although postoperative care of 
patients undergoing CABG, whether EVH or OVH, will likely be similar at each institution, 
differences in postoperative medication administration could also affect graft patency.  Because many 
different factors affect graft patency, establishing a causative relationship between vein harvest method 
and graft failure requires a clinical trial that also examines the aforementioned confounding variables 
and utilizes an objective endpoint measurement such as graft measurements via coronary angiography. 
 The purpose of this study is to systematically review recent literature regarding endoscopic 
vein harvest (EVH) versus open vein harvest (OVH) in CABG patients with regard to angiographic 
outcome. In patients undergoing CABG is there a decrease in angiographically measured graft patency 
when the saphenous vein is harvested endoscopically rather than by the traditional open method? The 
potential harm of EVH must be evaluated in the light of the large number of patients that undergo EVH 
annually as the predominant mode of saphenous vein harvest. 
 
General Operative Technique Background 
 Open harvest of the saphenous vein (OVH) is accomplished with a single long incision that 
stretches from the thigh to the medial malleous. The saphenous vein is removed as the incision 
progresses, while branches are clipped. In contrast, EVH involves a small, 2-3cm incision at or above 
the knee. This is used to identify and isolate the saphenous vein. A subcutaneous retractor and/or 
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endoscope is introduced into the subcutaneous tissue and advanced toward the groin or down towards 
the medial malleolus, as venous side branches are identified and clipped or cauterized.  A second, .5cm 
incision may be made near the distal end of the endoscope to secure the vein for removal. Many 
different brands of equipment exist for EVH, and carbon dioxide insufflation is frequently used to 
improve the visualization of the vein during harvest.8  EVH is technician and device dependant, thus as 
with many other surgical techniques, it takes practice to master. A 2005 study found that veins 
harvested with EVH required a significantly greater number of repairs as compared to OVH,4 these 
repairs have generally been attributed to the learning curve associated with mastering the EVH 
technique. It is unknown how these repairs affect graft patency. 
METHODS: 
 An exhaustive literature search was performed using OVID, Web of knowledge, EBMR, 
CINAHL, and clinicaltrials.gov with the following search terms: coronary artery bypass graft, 
endoscopy, saphenous vein, graft occlusion, and vascular patency. The initial articles were carefully 
reviewed to see if they met the inclusion criteria, and a secondary review of the bibliographies was 
conducted. In addition, a prospective and retrospective works cited search of articles included in this 
systematic review was completed. 
 
Eligibility criteria: 
 Studies were limited to only include those which compared EVH and OVH procedures in 
patients undergoing CABG and addressed angiographic measurements of graft patency. EVH was 
defined as harvest of the great saphenous vein using endoscopic instruments. OVH was defined as 
harvest of the saphenous vein using a continuous skin incision or several smaller incisions, known as a 
“bridging” technique.  One meta-analysis and one systematic review were excluded for review 
purposes, however their bibliographic works were utilized in obtaining articles for inclusion in the 
systematic review. Several trials examining graft patency in comparing EVH to OVH that utilized 
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clinical outcomes (such as myocardial infarction, revascularization, stroke or death) as surrogate 
endpoints were excluded. 
 Three studies were identified; two randomized controlled trials and one retrospective cohort 
study (see Table I). The three articles were assessed for quality and validity using an original scoring 
tool.  Points were awarded for prospective randomization to either EVH or OVH, for utilizing 
radiologists that were blinded to harvest method when reviewing the angiographic films, for describing 
the quality of vein graft and technique/experience of harvesting technician in methods, and for a large 
sample population size (see Table II). 
RESULTS:  
 The literature search identified three studies meeting eligibility criteria; two randomized 
controlled trials and one retrospective cohort study. Table III summarizes the demographics and results 
of these studies.   
 
Perrault et al9 
 A prospective randomized trial done by Perrault et al9 in 2004, included 40 adult patients 
undergoing a routine CABG, on or off pump, requiring >1 saphenous vein (SV) grafts. Patient 
characteristics were similar prior to randomization, including; age, sex, episodes of unstable angina, 
hypertension, chronic obstructive pulmonary disease (COPD), diabetes, 3-vessel disease, 2-vessel 
disease, and left ventricular (LV) ejection fraction .  The Vasoview system was used for EVH, it is 
unknown how much prior experience the technician performing the EVH had before the study. The 
quality of conduit, target vessel, and target vessel distribution is also unknown.  A coronary 
angiographic evaluation was performed on 27 OVH grafts and 32 EVH grafts one to nine months after 
surgery.  No statistical significance (p=.973, OVH 14.8% EVH 15.6%) of occlusion of saphenous vein 
grafts were found and no statistical significance of hemodynamically significant stenosis (p=.280, 
OVH 3.7% EVH 0%) were found (see Table III). 
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Yun et al5 
 A 2005 randomized trial done by Yun et al5 included 200 adult patients undergoing a routine 
CABG on pump requiring >1 SV grafts. Patient characteristics were similar prior to randomization 
including; age, sex, smoking history, hypertension, myocardial infarction, congestive heart failure, 
diabetes mellitus, peripheral vascular disease, carotid disease, stroke, and the designation of the New 
York Heart Association class (I-IV). 
  The Vasoview system was used for EVH, one physician assistant was utilized for each EVH 
surgery with case documentation of the PA’s prior EVH experience. The quality of each vein conduit 
was assessed intraoperatively by noting the conduit diameter and the number of conduit repairs 
needed. Additionally, target vessel atherosclerotic disease severity was assessed intraoperatively.  No 
significant differences were detected in the severity of target vessel disease or size, vein graft size or 
quality, or graft flow rates between the two groups.  
 Coronary angiography was performed six months postoperatively on 166 EVH grafts and 170 
OVH grafts. Overall graft occlusion rates at six months were 21.7% for EVH and 17.6% for OVH. 
Significant disease (>50% stenosis) was noted in an additional 10.2% of EVH grafts and 12.4% of 
OVH grafts (see Table III). A univariate analysis determined no significant difference in occlusion and 
disease rates in EVH as compared to OVH (p=.584).  A multivariable logistic regression found EVH to 
not be a significant factor for graft occlusion or disease (adjusted OR 1.15 [95% CI, 0.65-2.05] 
p=.594).  According to this study significant predictors for vein graft occlusion were congestive heart 
failure, vein graft to the diagonal territory, and larger vein graft size. Conversely, higher vein graft 
flow demonstrated a protective effect on the grafts. 
 
Lopes et al1 
 A recent (2009) retrospective cohort study by Lopes et al1 examined patients who were 
randomized into the PREVENT IV trial, a phase-III, multicenter, randomized double-blind placebo-
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controlled trial of ex vivo treatment of autologous vein grafts with edifoligide in patients undergoing 
initial CABG surgery10 on or off pump. Three thousand patients were enrolled at 107 sites in the 
United States. These patients were randomized to placebo or edifoligide, and the first 2400 patients 
were enrolled in coronary angiography cohort to evaluate graft patency 12-18 months following 
surgery.  Inclusion criteria for the PREVENT IV trial were patients 18-80 years old, who were 
undergoing a first isolated CABG with at least two planned vein-graft implantations. This trial 
included patients undergoing routine, urgent and emergent CABG procedures utilizing either EVH or 
OVH methods for saphenous vein harvest, occurring on or off pump. The enrolling center’s operating 
surgeon decided which method of harvest to utilize on a case by case basis.  
 Patient characteristics of the PREVENT trial were significantly different in that there was an 
increased proportion of African Americans (p<0.001), hypertensive patients (p=.01), patients with 
increased body mass index (p=.02), and fewer Hispanic patients (p<0.001) in the EVH cohort as 
compared to OVH.1 Other baseline patient characteristics between the groups did not demonstrate 
statistical significance.1 
 Intraoperative technician experience with EVH was not recorded, nor was the type of EVH 
device utilized. The quality of the target vessel was recorded intraoperatively as assessed by the 
operating surgeon, however, vein conduit quality was not recorded.  
 Coronary angiography was performed 12-18 months after surgery for 1817 patients. 2321 EVH 
grafts were analyzed and 1969 OVH grafts were analyzed. Overall graft failure was 27.2% for EVH 
and 22.6% for OVH (95% CI, OR 1.34 [1.14-1.59], p<0.001). Overall graft occlusion was 24.2% for 
EVH and 19.4% for OVH (95% CI, OR 1.39 [1.17-1.66], p<0.001), see Table III. Lopes et al1  used 
logistic-regression analysis to assess graft-failure outcomes per patient.  They report that their analysis 
adjusted for quality of the worst graft, the use of a composite or noncomposite graft, patient weight, 
duration of surgery, and quality of target artery. Lopes et al1 report a propensity score for endoscopic 
harvesting that included baseline variables other than the enrolling center, and still found the odds ratio 
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of vein graft failure to be 1.35 (95% CI, 1.15-1.60; p<0.001). Lastly, they concluded that there was no 
interaction between treatment with edifoligide and endoscopic harvesting for any of these outcomes.  
 
DISCUSSION:  
 The nature of examining saphenous graft patency necessitates that confounding variables or 
prognostic factors be taken into account. Grafts do not exist in a vacuum, a myriad of factors influence 
the longevity of graft patency. To isolate specifically endoscopic technique versus open technique as 
an independent risk factor for graft failure requires a cleanly run, large number, randomized study, 
with meticulous documentation of technique and confounding variables. These confounding variables 
can be categorized as preoperative, intraoperative and postoperative. Each study included in this 
systematic review had specific limitations in addressing these critical confounding factors. Therefore, 
the conclusion of each study regarding graft patency must be carefully evaluated based upon specific 
study limitations. 
Overview of variables: Preoperative,  Intraoperative,  Postoperative 
Preoperative 
Patient characteristics innately influence grafts.  However, ensuring statically similar patient 
populations through preoperative randomization should adjust for patient variation. 
Intraoperative 
Intraoperatively, there is a learning curve associated with EVH.4 Therefore, technician experience with 
EVH, including specific device, should be considered in evaluating graft patency. Additionally, data 
presented at the 2008 Annual Scientific Meeting of the International Society of Minimally Invasive 
Cardiothoracic Surgery, purported that administering heparin before vein harvest may improve graft 
patency, this data is not yet published. It has also been reported by Lamm11 that harvested grafts 
undergoing continuous perfusion with autologous blood, as compared to storage in a crystalloid 
solution, have significantly better endothelial integrity.11 To address these variables, a detailed clinical 
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trial should record the storage solution used for the conduit and should also document the time and 
dose of heparin administration. Additionally, the quality of vein conduit and target vessel should be 
recorded intraoperatively, so that poor quality conduits or target vessels effecting graft patency are not 
later attributed to harvesting technique. 
Postoperative 
Postoperatively, for patients undergoing CABG by either EVH or OVH, administering an antiplatelet 
drug has become standard therapy. The treatment effect of using aspirin versus clopidogrel is currently 
being studied, however Gao et al12 concluded that either clopidogrel plus aspirin or clopidogrel alone 
maintains high graft patency in the early postoperative phase after CABG. Documentation of post 
operative concomitant medications would be helpful in viewing graft patency data.  
 
Perrault et al9 
 The randomized clinical trial done by Perrault et al9 in 2004, used a relatively small sample size 
of 40 patients.  The patient characteristics prior to randomization were similar between the groups, 
however the overall sample did demonstrate a younger and more male dominated population,  (64 +/- 
7.9 years, with 1/15 women for OVH and 2/17 women for EVH), than the other two studies. Therefore, 
the applicability of this study to older women with potential more friable veins is uncertain. 
 Perrault et al9 failed to collect documentation of technician experience with a harvesting device 
in cases in which EVH was performed. Additionally, the quality of target vessel, vein conduit size, and 
vein quality were not assessed intraoperatively.  Perrault et al9 reported that “all native vessels had a 
high-grade stenosis of more than 70% (except one patient in each group) and [that] the majority were 
good target vessels for bypass grafting.” However, there were no clear methods reported for a 
standardized evaluation of these statements, so it is difficult to assess the validity of the study 
outcomes.  Also intraoperatively, there was no documentation as to whether heparin was administered 
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prior to vein harvest, and there was no documentation of which solution the harvested vessel was 
placed in prior to use for anastomosis. 
 Postoperatively, there was no documentation of whether clopidogrel was administered. 
Additionally, the coronorary angiographic follow up time period was not standardized. And although 
40 patients were randomized into the clinical trial , 8 patients refused postoperative angiography. 
These patients were not included in an intent to treat analysis. 
 Perrault et al9 failed to document many important intraoperative confounding variables in their 
trial. The validity of the coronary angiographic measurement data is therefore difficult to assess. For 
instance, utilization of a lower quality vein conduit will likely later result in decreased graft patency. 
That patency may be a reflection of the lower quality vein, or it may be a reflection of the method of 
vein harvest. Without meticulous documentation the data is less meaningful. 
 Perrault et al9recognized that their relatively early (1-9 months post surgery) angiographic 
assessment was of limited use in evaluating late graft intimal  hyperplasia and subsequent stenosis. 
However, they concluded that their data demonstrated a lack of vein trauma and subsequent early 
conduit stenosis that was previously associated with EVH. Vein graft occlusion rates 1-9 months after 
surgery in this study were 14.8% for OVH and 15.6% for EVH, p=.973, a statistically insignificant 
value. The limitations of this study are many and are highlighted above. However, as the first study 
comparing EVH to OVH in regard to graft patency via angiographic evaluation, this study served as a 
basis for further research to build upon in establishing more applicable validity criteria for further 
research. 
 
Yun et al5 
 Yun et al5 conducted a relatively meticulous trial that is frequently referenced in the EVH 
versus OVH debate. Many shortcomings present in the Perrault et al9 trial were absent here. For 
example, a larger original sample size of 200 patients was utilized in a randomized trial of EVH versus 
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OVH. Patient characteristics preoperatively were similar between the two groups. The interoperative 
documentation was remarkable in that many important operative variables were recorded for each 
patient. These included; vein conduit quality, atherosclerotic disease of the target vessel, technician 
experience, and specific EVH device. Yun et al5 additionally recorded that the patients were 
heparinized prior to saphenous vein harvest, and that the harvested vein was kept in a solution of 
heparinized blood with papavarine prior to anastomosis. 
 One of the few flaws of the trial was the relatively small sample size of the study, which 
limited its statistical power. Although 200 patients were randomized into this study, 56 refused 
angiographic follow-up. Therefore, 166 EVH grafts and 170 OVH grafts were analyzed.  The 
angiographic evaluation was completed at six months post surgery, this was a rather short timeframe 
for angiographic patency evaluation. Also postoperatively, it was not noted if patients received 
clopidogrel or another anti-platelet drug.  Despite these flaws, the study design was well thought out 
and executed.  
 Yun et al5 concluded that there was no statistically significant difference in graft occlusion and 
disease rates in EVH as compared to OVH six months after surgery.  Vein graft occlusion rates were 
21.7% for EVH and 17.6% for OVH, p=.584. This trial remains one of the more often cited studies 
demonstrating comparable saphenous graft patency rates regardless of harvest technique.  The 
inclusion of so many confounding variables allowed for a more detailed examination of the correlation 
between method of harvest and graft patency.  
 
Lopes et al1 
 Lopes et al1 concluded that patients who underwent EVH had higher rates of vein-graft failure 
than patients who underwent OVH, this was 27.2% for EVH and 22.6% for OVH ,p<0.001.  
Additionally, they found 24.2% of EVH and 19.4% of OVH grafts to be fully occluded p<0.001.  
However, the conclusions of Lopes et al1 were based upon a retrospective cohort study in which the 
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primary randomization was for edifoligide versus placebo, harvest method was not a predefined 
subanalysis for this study.  
 In the evaluation of graft patency, the methods of the Lopes et al1 study were flawed.  First, the 
operating surgeon determined the method of saphenous vein harvest on a case by case basis, without 
randomization.  Also, this study was multi-centered, institution case experience as well as operator 
experience with EVH varied. However, neither of these variables was documented. A so-called “center 
affect” is mentioned in the article by Lopes et al1, the authors report that the association between vein 
graft failure and EVH was no longer significant when statistically adjusted for enrolling centers that 
utilized both EVH and OVH.1 This suggests that vein graft failure may more closely correlate to the 
center in which the harvesting procedure and surgery is done. 
  The Lopes et al1 study included emergent, urgent, and routine CABG surgeries in the data 
analysis. The effect of emergent or urgent surgery on graft quality has not been studied.  Of further 
concern is that no adjustment was made for off-pump or left internal thoracic artery grafts.  In a 
separate analysis of the PREVENT IV data, off-pump bypass with the use of internal thoracic artery 
grafts was shown to increase graft failure.13 Also, although vein quality was mentioned, methods used 
to quantify vein quality were not documented.  Target vessel quality was also not documented.  It was 
not noted which solution the harvested vessel was stored in prior to anastomosis. Finally, this study 
also included the use of edifoligide. It is unclear how this pharmacologic variable may effect the 
outcome of angiographic graft patency. 
 The largest factor affecting the validity of the Lopes et al1 trial is the lack of prospective 
randomization for the intervention studied.  Despite the author’s efforts to statistically adjust for this, 
the trial was not designed to assess method of harvest related to graft patency.  The lack of a 
predetermined subanalysis in this study, combined with the lack of documentation of almost all of the 
essential confounding variables are insurmountable problems effecting the validity of this study’s 
conclusion. In correspondence with the NEJM, Dr. Connolly, a cardiothoracic surgeon at Boston 
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University Medical Center, notes “limitations of the post hoc, retrospective analysis of PREVENT IV 
data by Lopes et al1 preclude a definitive attribution of negative outcomes to endoscopic vein-graft 
harvesting, rather than to confounding factors.”14  
 
CONCLUSION: 
 The question remains, does overall graft patency depend on confounding variables such as 
target related variables and patient related characteristics or can it be independently linked to harvest 
method? In studies with long-term angiographic follow-up utilizing conventional OVH, the incidence 
of vein graft occlusion is 15% to 20% at one year.15 This number is not precise, as actual occlusion 
rates are difficult to collect. However, using these numbers as a general range, the Lopes et al1 trial 
was the only trial with EVH occlusion rates significantly higher than is typical for OVH occlusion 
rates. 
 Further research is needed to adequately address confounding variables contributing to graft 
failure, and therefore permit a more accurate assessment of the impact of harvest technique on graft 
patency. Ideally, a prospective randomized controlled trial examining EVH versus OVH in patients 
undergoing CABG would be performed. The study should include a population of at least 400 patients, 
with prospective randomization to EVH or OVH, in patients undergoing routine CABG on or off 
pump. The study should follow the technique of Yun et al5 in recording operative procedure including; 
type of harvesting device used, operator experience with the device, documentation of heparin 
administration prior to vein harvest, storage solution of conduit prior to anastomoses, quality of 
conduit as assessed by a standardized method, and quality of target vessel as assessed by the operating 
surgeon. Post operative documentation should include a list of concomitant medications maintained 
through the conclusion of the trial. Angiographic follow-up should be performed at six months post 
surgery and again at 18 months post surgery. The radiologist interpreting the angiogram should be 
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blinded to harvest method.  A trial with adequate power including these confounding variables would 
more accurately assess the link between graft patency and harvesting technique. 
 The limited state of current research has failed to demonstrate significant harm that may 
otherwise persuade the Society for Thoracic Surgery and the Association of Physician Assistants in 
Cardiovascular Surgery (APACVS) to negate the important proven benefits of EVH over OVH. These 
benefits are landmark in their own right.  As mentioned previously they include; decreased wound 
morbidity, decreased infection rates, and decreased length of hospital stay. The APACVS, in a meeting 
held in January of 2010, noted a need for more randomized clinical trials utilizing so-called “best 
practices” that address the confounding variables noted in this systematic review.  It was noted that in 
general “best practices” would include: an experienced vein harvester, utilization of veins in the lower 
leg, preheparinization prior to vein harvest, non-thermal side branch ligation, prevention of over-
distension of the conduit through use of a pressure pop-off syringe, minimization of traction on the 
harvested vein, and demonstrated patience by the operating cardiothoracic surgeon. 
 Widespread adaptation of best practices may more easily allow for an angiographic patency 
comparison between EVH and OVH to be completed across multiple surgical centers. More 
importantly, the adaptation of best practices will ultimately contribute to better patient outcomes. Until 
further research is completed, EVH remains the preferred method of saphenous vein harvest. 
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Table I Summary of Reviewed Articles 
Author/  
Title/ 
Journal 
Yr.  
enroll
ed 
Study Type Patients/  
Population 
Intervention Comparison Outcome(s) 
Angiographic 
p Value Validity 
 Score 
Comments 
Perrault LP 
et al9 
2000-
2002 
Randomized 40 patients 
routine CABG  on or off 
pump requiring >1 SV 
graft 
 
27 OVH grafts 
32 EVH grafts 
 
EVH of SV 
by Vasoview 
system 
OVH 1-9 months 
Stenosis + 
occlusion 
Occlusion 
p=.933 
 
HSS p=.280 
2/9 Occlusion= 100% of 
luminal diameter 
 
Hemodynamically sig 
stenosis= 50-99% 
Yun KL et 
al5 
2000-
2002 
Randomized 200 patients 
Routine CABG on pump 
requiring >1 SV graft 
with sufficient 
subcutaneous tissue for 
EVH device insertion 
 
170 OVH grafts 
166 EVH grafts 
EVH of SV 
by Vasoview 
system 
OVH 6 month 
 
Stenosis + 
occlusion 
  
Occlusion 
and 
Significant 
disease 
 
p=.584 
8.5/9 Occlusion=100% of 
luminal diameter 
 
Significant disease= 
>50% stenosis 
Lopes R et 
al1 
2002-
2003 
Retrospective 
Cohort  
2400 patients in 
angiographic cohort 
Randomized double-
blind placebo controlled- 
edifoligide in patients 
having CABG 
(Emergent, Urgent or 
Routine) on or off pump 
requiring >2 SV grafts 
 
1969 OVH grafts  
2321 EVH grafts  
EVH of SV, 
unknown 
system 
 
 
Edifoligide 
OVH 
  
 
 
 
Placebo 
12-18 months 
 
Graft failure 
 
 
 
Graft 
occlusion 
 
 
  
Graft failure 
p<.001 
 
 
Graft 
occlusion 
p<.001 
2/9 Multi-center study 
No randomization 
 
Vein Graft Failure= 
75% of diameter of 
graft stenosed 
 
Occlusion=100% of 
luminal diameter 
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Table II- Validity Score 
Criteria +1 pt -1pt 
Study Type Prospective 
Randomized 
Retrospective Cohort 
Study personnel (Radiologist) blinded to 
intervention method 
Yes No or can’t tell 
Sample Size >200 <200 
Statistically similar patient Characteristics at the 
start of the trial 
yes no 
Were patient analyzed in the  groups to which 
they were randomized (intent to treat)? 
Yes no 
Operative technique: (2pts, ½ point each) 
• Harvesting personel experience documented 
• Type of EVH device used documented 
• Type of solution for harvested vein documented 
• Heparin prior to harvest documented 
Quality (1pt, ½ point each) 
• target vessel quality measured 
• vein conduit quality measured and documented 
PostOperative (1pt, ½ point each) 
• groups treated the same 
• documentation of clopidogrel administered 
9 points possible 
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Table III- Summary of Findings 
 Perrault et al9 2004 
Randomized Trial 
Yun et al5 2005 
Randomized Trial 
Lopes et al1 2009 
Retrospective Cohort 
Harvest Method  EVH  OVH  EVH  OVH  EVH  OVH  
Total Number of 
grafts  
32  27  166  170  2321  1969  
Occluded Grafts  15.6%  14.8%   21.7%  17.6%  24.2%  19.4%  
Plus Stenosis or 
Significant 
disease  
0%  3.7%  10.2%  12.4%  27.2%  22.6%  
P value  Occluded Grafts   p=.973  
 
Stenosed or Significant 
disease Grafts   p=.280  
Occluded  and  
Significantly Stenosed 
Grafts     
 
p=.584  
Occluded Grafts   
 p<0.001 
 
Stenosed Grafts 
p<0.001 
 
 
 
 
 
 
 
 
